These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9888646)

  • 1. Effects of fibric acid derivatives and metformin on postprandial lipemia.
    Weintraub MS; Charach G; Grosskopf I
    Atherosclerosis; 1998 Dec; 141 Suppl 1():S71-5. PubMed ID: 9888646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects.
    Grosskopf I; Ringel Y; Charach G; Maharshak N; Mor R; Iaina A; Weintraub M
    Diabetes Care; 1997 Oct; 20(10):1598-602. PubMed ID: 9314642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosis.
    Weintraub MS; Grosskopf I; Charach G; Mor R; Rubinstein A; Wollman Y; Judevices R; Iaina A
    Metabolism; 1995 Nov; 44(11):1401-9. PubMed ID: 7476325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
    Krause BR; Barnett BC; Essenburg AD; Kieft KA; Auerbach BJ; Bousley R; Stanfield R; Newton RS; Bisgaier CL
    Atherosclerosis; 1996 Nov; 127(1):91-101. PubMed ID: 9006809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome.
    Ooi TC; Simo IE; Yakichuk JA
    Arterioscler Thromb; 1992 Oct; 12(10):1184-90. PubMed ID: 1390590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.
    Simo IE; Yakichuk JA; Ooi TC
    Atherosclerosis; 1993 Apr; 100(1):55-64. PubMed ID: 8318063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
    Weintraub MS; Eisenberg S; Breslow JL
    J Clin Invest; 1987 Apr; 79(4):1110-9. PubMed ID: 3470306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia.
    Santos RD; Ventura LI; Spósito AC; Schreiber R; Ramires JA; Maranhão RC
    Cardiovasc Res; 2001 Feb; 49(2):456-65. PubMed ID: 11164856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment.
    Autran D; Attia N; Dedecjus M; Durlach V; Girard-Globa A
    Atherosclerosis; 2000 Dec; 153(2):453-60. PubMed ID: 11164435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of small high-density lipoprotein particles after stimulation of in vivo lipolysis in hypertriglyceridemic individuals: studies before and after triglyceride-lowering therapy.
    Lewis GF; Uffelman KD; Lamarche B; Cabana VG; Getz GS
    Metabolism; 1998 Feb; 47(2):234-42. PubMed ID: 9472977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the postprandial lipid metabolism: use of a 3-point test.
    Guerci B; Paul JL; Hadjadj S; Durlach V; Vergès B; Attia N; Girard-Globa A; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):449-57. PubMed ID: 11547218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
    Mamo JC; Watts GF; Barrett PH; Smith D; James AP; Pal S
    Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E626-32. PubMed ID: 11500319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin A loading--an indicator of post-prandial lipoprotein clearance in healthy and hypertriglyceridemic subjects.
    Rassin T; Liron M; Rubinstein A; Arad J; Weintraub M
    Isr J Med Sci; 1992 Oct; 28(10):706-10. PubMed ID: 1399499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect Of bezafibrate treatment.
    Attia N; Durlach V; Cambilleau M; Roche D; Girard-Globa A
    Atherosclerosis; 2000 Apr; 149(2):427-33. PubMed ID: 10729394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
    Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
    Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women.
    Weintraub M; Grosskopf I; Charach G; Eckstein N; Rubinstein A
    Metabolism; 1999 Sep; 48(9):1193-6. PubMed ID: 10484063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.